News & Analysis as of

China Joint Venture

Braumiller Law Group, PLLC

Hot Topics in International Trade - August 2024 - Coming Soon: A New Polar Icebreaker Competition in the Arctic Region for Trade...

The US, Canada, and Finland are launching a joint partnership to build more ice-breaking ships to compete with China and Russia in Arctic. Sad but true, here we go again. Whether it’s the South China sea, or even the moon,...more

Hogan Lovells

Advising China Baowu Steel Group on the closing of its investment in the largest mining and infrastructure project in Africa.

Hogan Lovells on

Hogan Lovells advises longstanding client, the world's largest steelmaker, China Baowu Steel Group (Baowu) on its investment in the Simandou mining and infrastructure project in the Republic of Guinea, West Africa. Simandou...more

Hogan Lovells

Changing the legal representative in China is about to become much easier

Hogan Lovells on

One of the key challenges for creditors in taking control of a mainland Chinese company in an enforcement type situation is how to remove the “legal representative”. New legislation coming into force on 1 July 2024 should...more

Skadden, Arps, Slate, Meagher & Flom LLP

2024 Insights: Corporate Trends

Global M&A Activity Endures Headwinds in 2023 and Displays Resilience Going Into 2024 - Despite market headwinds, dealmakers have looked to carveouts, spin-offs, joint ventures and other creative deal structures to engage...more

Holland & Knight LLP

Holland & Knight's China Practice Newsletter: March-April 2023

Holland & Knight LLP on

Holland & Knight invites you to read our China Practice Newsletter, in which our authors discuss pertinent Sino-American topics. ...more

Skadden, Arps, Slate, Meagher & Flom LLP

Demystifying China’s Merger Review Process

China’s merger clearance authority plays a critical role in global M&A, even for deals that have few obvious ties to China. Particularly in the technology area, China is often the last hurdle to clear. Moreover, unlike those...more

Skadden, Arps, Slate, Meagher & Flom LLP

The Informed Board - Fall 2022

The proliferation of U.S. sanctions and other regulations affecting cross-border transactions has implications for directors, who may be personally liable for violations in some cases. Meanwhile, the Securities and Exchange...more

Hogan Lovells

SAMR delegates merger review powers

Hogan Lovells on

Yesterday, on 29 August 2022, clearance for the FAW/Refire joint venture transaction was announced on one of the websites of the Chinese antitrust authority – i.e., the State Administration for Market Regulation. That...more

Pillsbury Winthrop Shaw Pittman LLP

Investment Opportunities Abound in Japan’s M&A Market

The outlook for inbound mergers and acquisitions opportunities in Japan is bright with the yen at a 20-year low. The yen’s recent plunge to around 135 to the U.S. dollar has made Japanese assets approximately 20% cheaper...more

Orrick, Herrington & Sutcliffe LLP

The Practical Implications of the EU-China Investment Deal

On December 30, 2020, the EU and China announced the conclusion of the negotiations of the investment treaty, the EU-China Comprehensive Agreement in Investments (CAI). The CAI represents a strategic opportunity for EU...more

Morrison & Foerster LLP

Top 10 International Anti-Corruption Developments For August 2020

In order to provide an overview for busy in-house counsel and compliance professionals, we summarize below some of the most important international anti-corruption developments from the past month, with links to primary...more

Goodwin

Bio-Thera Solutions and BeiGene Announce Agreement for the Rights to Bio-Thera’s Avastin Biosimilar BAT1706 in China

Goodwin on

Last week, BeiGene and Bio-Thera Solutions announced that the companies had entered into a license, distribution, and supply agreement for BAT1706, Biothera’s Avastin® (bevacizumab) biosimilar, in China. According to the...more

Pillsbury Winthrop Shaw Pittman LLP

Implementing China’s New Foreign Investment Law, Part Five: Exit Options for Investors of Foreign Invested Enterprises

The fifth and final installment of a series of alerts focusing on practical issues relating to China’s new Foreign Investment Law. Foreign investors seeking to exit from their existing foreign invested enterprises (FIEs)...more

Pillsbury Winthrop Shaw Pittman LLP

Implementing China’s New Foreign Investment Law, Part Three: Changes to Corporate Governance of Sino-Foreign Joint Ventures

The third installment of a series of alerts focusing on practical issues relating to China’s new Foreign Investment Law. There are major differences in the requirements on corporate governance and decision-making...more

Hogan Lovells

GMCQ: Global Media, Technology and Communications Quarterly – Spring/Summer 2020

Hogan Lovells on

COVID-19 and IT service provider contracts: A checklist for force majeure events - The COVID-19 pandemic, and the various restrictions that have been implemented in response to it, are causing extraordinary business...more

Sheppard Mullin Richter & Hampton LLP

CFIUS Update Issue — CFIUS Scrutiny in Biotech: The Ekso Case and the Eye of the Terminator

Robotic exoskeletons may augment human strength, endurance, and mobility. The latest CFIUS action has all the makings of a Terminator movie. This month, the Committee on Foreign Investment in the United States (“CFIUS”)...more

Skadden, Arps, Slate, Meagher & Flom LLP

China Publishes Draft Amendments to Anti-Monopoly Law

For the first time since China’s Anti-Monopoly Law (AML) came into force in 2008, the government is proposing major changes to its centerpiece antitrust legislation. On January 2, 2020, the State Administration for Market...more

Hogan Lovells

Coronavirus FAQ: Key corporate and commercial considerations

Hogan Lovells on

The global outbreak of the novel coronavirus COVID-19 is having profound implications for businesses all over the world. A Hogan Lovells team of corporate and commercial lawyers from the United Kingdom, United States, and...more

Jones Day

China Further Opens its Market with New "Foreign Investment Law"

Jones Day on

The Situation: The new PRC Foreign Investment Law ("FIL"), as well as its Implementing Regulations ("Implementing Regulations"), took effect on January 1, 2020. In addition to the FIL and the Implementing Regulations, the...more

Hogan Lovells

Impact of the Coronavirus outbreak on M&A and JV Transactions

Hogan Lovells on

The outbreak of novel coronavirus 2019-nCoV ("Coronavirus") is an extraordinary challenge for many transactions involving Chinese companies. In this section, we analyse its impact on certain key aspects of mergers and...more

Goodwin

Biosimilar and Biologic Business Developments Update – Collaborations and Licensing Deals

Goodwin on

Last week, Almirall signed an agreement with WuXi Biologics to collaborate on multiple bispecific antibodies targeting dermatology conditions, including atopic dermatitis. Almirall’s press release indicated that, “[u]nder the...more

Thomas Fox - Compliance Evangelist

Bribery Schemes from 2019 FCPA Enforcement Actions

In today’s blog post, I want to look at some of the more unusual bribery schemes from Foreign Corrupt Practices Act (FCPA) enforcement actions in 2019. Some of these schemes were not unusual but they were accomplished with...more

White & Case LLP

Recent Developments in IP Protection in China

White & Case LLP on

The National People’s Congress of China (NPC) adopted the new Foreign Investment Law (FIL) on March 15, 2019, with a view toward unifying and streamlining the foreign investment framework into China.  One of the main emphases...more

Akin Gump Strauss Hauer & Feld LLP

2019 Negative List Article

The National Development and Reform Commission and the Ministry of Commerce jointly released the new Special Administrative Measures (Negative List) for the Access of Foreign Investment (2019) in China (the “2019 Negative...more

Hogan Lovells

China's new Foreign Investment Law: the impact on financial institutions

Hogan Lovells on

Much has already been written about the foreign investment law which was voted into law by China's highest legislative body, the National People's Congress of the People's Republic of China, on 15 March 2019. ...more

74 Results
 / 
View per page
Page: of 3

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide